Volume 44, Issue 4, Pages (April 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
TLR4 signal ablation attenuated neurological deficits by regulating microglial M1/M2 phenotype after traumatic brain injury in mice  Xiaolong Yao, Shengwen.
Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic.
Volume 46, Issue 3, Pages (March 2007)
Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities  Apostolos K. Tassiopoulos, MD,
Inflammasomes in liver diseases
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver  Lin Nanna Okholm Møller, Anders Riegels Knudsen,
Volume 58, Issue 6, Pages (June 2013)
International Journal of Surgery
Contribution of nitric oxide synthase (NOS) in blood–brain barrier disruption during acute focal cerebral ischemia in normal rat  Mohammad T. Mohammadi,
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Jeanwan Kang, MD, Hassan Albadawi, MD, Patrick J. Casey, MD, Thomas A
Human-Hemato-Lymphoid-System Mice: Opportunities and Challenges
Clinical Nutrition Experimental
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
International Journal of Surgery
Volume 41, Issue 3, Pages (September 2004)
Omega 3 – Omega 6: What is right for the liver?
Volume 42, Issue 4, Pages (April 2005)
Living donor liver transplantation: is the hype over?
Preoperative dietary restriction reduces intimal hyperplasia and protects from ischemia- reperfusion injury  Christine R. Mauro, MD, Ming Tao, MD, Peng.
Volume 42, Issue 4, Pages (April 2005)
Volume 41, Issue 5, Pages (November 2004)
Volume 44, Issue 6, Pages (June 2006)
Volume 58, Issue 6, Pages (June 2013)
Volume 23, Issue 3, Pages (September 2016)
ESR measurement of endogenous nitric oxide in liver and blood of mice subjected to hepatic ischemia-reperfusion  Fusako Takayama, Toru Egashira, Yasumitsu.
Volume 42, Issue 6, Pages (June 2005)
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Volume 61, Issue 2, Pages (August 2014)
Hepatitis C core protein – The “core” of immune deception?
Volume 62, Issue 5, Pages (May 2015)
Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities  Apostolos K. Tassiopoulos, MD,
Volume 41, Issue 2, Pages (August 2004)
Volume 59, Issue 3, Pages (September 2013)
Volume 62, Issue 3, Pages (March 2015)
Neuroprotection following mild hypothermia after spinal cord ischemia in rats  Takeshi Saito, PhD, Shino Saito, MD, Hiroshi Yamamoto, MD, PhD, Masanori.
Volume 39, Issue 4, Pages (October 2003)
JNK mediates hepatic ischemia reperfusion injury
Volume 41, Issue 3, Pages (September 2004)
EASL Clinical Practice Guidelines: Wilson’s disease
Cytokines contribute to early hepatic parenchymal injury and microvascular dysfunction after bilateral hindlimb ischemia  D.Kirk Lawlor, MD, Robert W.
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Nobuhiko Takahashi, Yong Qi, Hiral R. Patel, Rexford S. Ahima 
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Dose-dependent neuroprotection of delta-opioid peptide [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into.
Solutions to the discrepancies in the extent of liver damage following ischemia/reperfusion in standard mouse models  Rowan F. van Golen, Megan J. Reiniers,
Hong T. Hua, MD, Hassan Al-Badawi, MD, Fateh Entabi, MD, Michael C
Volume 50, Issue 3, Pages (March 2009)
Volume 64, Issue 6, Pages (June 2016)
Induction of heat shock protein 70 inhibits ischemic renal injury
Ischemic preconditioning ameliorates spinal cord ischemia-reperfusion injury by triggering autoregulation  Cheng-Loong Liang, MD, Kang Lu, MD, PhD, Po-Chou.
Volume 13, Issue 1, Pages (January 2006)
Volume 64, Issue 1, Pages (January 2016)
Determinants of ischemic injury to skeletal muscle
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Volume 75, Issue 5, Pages (March 2009)
Volume 61, Issue 2, Pages (August 2014)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Protective strategies against ischemic injury of the liver
Volume 75, Issue 5, Pages (March 2009)
Richard A. Zager, Ali Johnson, Sherry Hanson, Vivian Dela Rosa 
Volume 44, Issue 5, Pages (May 2006)
Volume 64, Issue 6, Pages (June 2016)
Captopril in Cardioplegia and Reperfusion: Protective Effects on the Ischemic Heart  Jacob Gurevitch, Dimitri Pevni, Inna Frolkis, Menachem Matsa, Yosi.
Volume 38, Issue 1, Pages (January 2003)
Presentation transcript:

Volume 44, Issue 4, Pages 694-701 (April 2006) Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis  Nazia Selzner, Markus Selzner, Wolfram Jochum, Beatrice Amann-Vesti, Rolf Graf, Pierre-Alain Clavien  Journal of Hepatology  Volume 44, Issue 4, Pages 694-701 (April 2006) DOI: 10.1016/j.jhep.2005.07.032 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Pattern of fat distribution in lean and fatty livers. (a) Total amount of intrahepatic lipid content in lean and fatty mice. Both ob/ob and choline deficient mice contained comparable amounts of intrahepatic lipid (56±23.4 and 57.5±10.4μg/mg of protein, respectively), which was five times higher than lean control mice (9.6±4μg/mg of protein) (n=5, in each group, *P<0.05, Student's t-test). (b) Macro- vs. microvesicular steatosis in ob/ob and choline deficient mice. Ob/ob mice had a significantly larger preponderance of macrovesicular (58±6%) vs. microvesicular (27.5±4.4%) steatosis. In contrast, the liver from mice with a choline deficient diet contained a higher percentage of micro (66.7±5%) than macrovesicular (16.7±4.5%) inclusion (n=5 in each group, *P<0.05, Student's t-test). (c) Oil-red O stained section from the lean and fatty livers. Ob/ob mice had a higher predominance of macro- vs. microvesicular fat in the liver. In contrast, the liver of the choline deficient mice contained a higher percentage of micro than macrovesicular steatosis. Of note, no fat staining was observed in the lean animals. Magnification of the histologic sections ×100 (For interpretation of the reference to colour in this legend, the reader is referred to the web version of this article.). Journal of Hepatology 2006 44, 694-701DOI: (10.1016/j.jhep.2005.07.032) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 AST levels after reperfusion. Ob/ob ▪ mice had a significantly higher AST release at 30min (7433±713U/l) and 4h (19940±4471U/l) after reperfusion compared to choline deficient mice ▴ (4933±309 and 8025±998IU/ml) and to the lean controls ♦ (4033±601 and 6873±873U/l). In contrast to the lean mice, AST levels increased in the choline deficient mice at later time of reperfusion, with values comparable to the ob/ob mice (14–500±3395 vs. 16,566±5731U/l) at 24h of reperfusion (n=5 in each group, *P<0.05 compared to the choline deficient and lean animals, **P<0.05 compared to the lean animals, Student's t-test). Journal of Hepatology 2006 44, 694-701DOI: (10.1016/j.jhep.2005.07.032) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Necrosis in liver tissue after reperfusion. (a) Four hours after reperfusion □, Ob/ob mice had a significantly higher percentage of necrosis (70±8.5%) compared to choline deficient (26±5%) and to the lean controls (14±3%). *P<0.05. (b) At 24h of reperfusion ▪, only a small percentage of necrosis was noted in lean animals (25±12%), while both macro- (80±21%) and microvesicular (65±24%) steatosis were associated with large area of necrosis (n=5 in each group,**P<0.05, Student's t-test). Journal of Hepatology 2006 44, 694-701DOI: (10.1016/j.jhep.2005.07.032) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Intrahepatic energy content in liver tissue. Both types of fatty livers (ob/ob ▪ and choline deficient ▴) had lower ATP levels at baseline (sham) as well as at different times of reperfusion in comparison to the lean mice (♦). However, no difference was observed regarding ATP contents between the two types of fatty livers. Journal of Hepatology 2006 44, 694-701DOI: (10.1016/j.jhep.2005.07.032) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Portal vein and sinusoidal flow after reperfusion. (a) Ob/ob mice (▪) had a significantly higher drop on portal vein flow after 45min of ischemia (18±2.5%). *P<0.05 compared to choline deficient (▴) (60±5%) and lean (♦) mice (55±7%) (n=5 in each group). (b) Similarly, Ob/ob (▪) mice had also a significant higher drop of sinusoidal flow after 45min of ischemia (31±2.5%). *P<0.05, compared to choline deficient (▴) (72±5%) and lean (♦) mice (86±7%) (n=5 in each group). Journal of Hepatology 2006 44, 694-701DOI: (10.1016/j.jhep.2005.07.032) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 6 AST levels and necrosis in liver tissue after ischemic pre-conditioning. (a) Ischemic pre-conditioning improved AST level in both macro- (13,620±4692U/l) and microvesicular (3975±869U/l) steatosis in comparison with their respective control group without pre-conditioning (19940±4471 and 8025±998U/l) (n=5 in each group, *P<0.05, Student's t-test). (b) Necrosis in liver tissue was significantly improved in the pre-conditioning groups in both macro- (24±3%) and microvesicular (6±0.2%) steatosis compared to their respective control group without pre-conditioning (70±8.5%) and (26±5%) (n=5 in each group, *P<0.05, Student's t-test). Journal of Hepatology 2006 44, 694-701DOI: (10.1016/j.jhep.2005.07.032) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 7 Portal vein and sinusoidal flow after ischemic pre-conditioning. Portal vein blood flow and sinusoidal flow were investigated immediately after 45min of ischemia and 4h of reperfusion. (a and b) Pre-conditioning improved portal vein flow in both types of fatty livers (Ob/ob, choline deficient) and lean animals at the end of ischemia (a) and after 4h of reperfusion (b). The protection conferred by ischemic pre-conditioning was more prominent in microvesicular steatosis with a complete recovery of portal vein flow to baseline values (100%) after 4h of reperfusion compared to their control group without pre-conditioning (*P<0.05). In contrast, despite ischemic pre-conditioning the portal vein flow in macrovesicular fatty livers remained impaired with 69% of the baseline flow (**P<0.05) (n=5 in each group). (c and d) Pre-conditioning improved sinusoidal flow in both types of fatty livers (Ob/ob, choline deficient) and also in lean mice at the end of ischemia (c) and after 4h of reperfusion (d) compared to their respective control group without pre-conditioning (Ob/ob, choline deficient and lean) (*P<0.05, n=5 in each group). Journal of Hepatology 2006 44, 694-701DOI: (10.1016/j.jhep.2005.07.032) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions